Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — The 2022 American College of Rheumatology recommendations on integrative therapy in rheumatoid ...

Morning stiffness is common for people with arthritis and that got researchers to thinking that if they could time drug therapy to match the body’s rhythms when pain receptors are most active, they ...

NEW YORK — Patients with rheumatoid arthritis (RA) carry a high risk for cardiovascular events, but mounting clinical evidence suggests they're being undertreated to manage that risk. Rheumatologists ...

AndHealth, a health care company based in Ohio, is making notable progress in combating autoimmune conditions through an observational study named Project IMPACT. This study seeks to show that it’s ...

Advances in biotechnology, a greater understanding of the immunopathogenesis of rheumatoid arthritis (RA) and a desire for more effective therapeutics have led to the development of a class of ...

Polypharmacy was linked to a lower likelihood of achieving remission and an increased risk for serious adverse events among patients with early rheumatoid arthritis. Polypharmacy (PP) was ...

Treating rheumatoid arthritis (RA) typically means taking drugs to address the inflammatory process that leads to joint pain in RA. These drugs may be taken by mouth, or by injection or infusion. But ...

A study looked at more than 23,600 Medicare beneficiaries with RA who had received a ≥30-day prescription of an opioid drug. Participants were grouped according to those who had been prescribed a ...

RA can affect your lifespan in various ways related to cardiovascular disease, lung disease, infection, depression, and ...

This article was originally published by HCPLive. The American College of Rheumatology (ACR) released 2 clinical practice guidelines for the screening, monitoring, and treatment of interstitial lung ...